Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
- Revenue in USD (TTM)1.32bn
- Net income in USD175.44m
- Incorporated1985
- Employees3.02k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
Mergers & acquisitions
| Acquired company | HAE:NYQ since announced | Transaction value |
|---|---|---|
| Vivasure Medical Ltd | -32.16% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AxoGen Inc | 214.71m | -2.10m | 1.70bn | 451.00 | -- | 12.94 | 350.16 | 7.91 | -0.0486 | -0.0486 | 4.56 | 2.62 | 1.05 | 1.55 | 7.75 | 476,073.20 | -1.03 | -11.36 | -1.17 | -13.05 | 74.76 | 78.42 | -0.9767 | -15.37 | 2.64 | 0.6493 | 0.2852 | -- | 17.81 | 11.91 | 54.12 | -- | -2.84 | -- |
| Pulse Biosciences Inc | 86.00k | -74.73m | 1.71bn | 75.00 | -- | 18.45 | -- | 19,896.88 | -1.14 | -1.14 | 0.0013 | 1.37 | 0.0009 | -- | -- | 1,146.67 | -74.06 | -83.75 | -80.63 | -94.40 | -224.42 | -- | -86,898.84 | -12,644.52 | 10.01 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| Artivion Inc | 422.65m | -9.12m | 1.90bn | 1.60k | -- | 4.33 | 137.12 | 4.49 | -0.242 | -0.242 | 9.48 | 9.26 | 0.509 | 1.72 | 5.16 | 264,153.80 | -1.10 | -2.47 | -1.29 | -2.66 | 64.50 | 65.02 | -2.16 | -5.89 | 2.88 | 1.29 | 0.3324 | -- | 9.75 | 7.06 | 56.37 | -- | 6.75 | -- |
| Quidelortho Corp | 2.71bn | -1.18bn | 1.96bn | 6.60k | -- | 0.9603 | -- | 0.7208 | -17.38 | -17.38 | 40.11 | 29.99 | 0.4351 | 2.41 | 7.18 | 411,272.70 | -18.91 | 0.0044 | -22.09 | 0.005 | 47.15 | 59.13 | -43.45 | 0.009 | 0.9805 | 0.6537 | 0.5663 | 0.00 | -7.17 | 39.07 | -20,216.83 | -- | 48.27 | -- |
| Inspire Medical Systems Inc | 911.98m | 56.67m | 1.98bn | 1.25k | 35.29 | 2.50 | 28.05 | 2.17 | 1.93 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | -- | 6.61 | 0.0716 | 7.40 | 0.0806 | 85.39 | 84.83 | 6.21 | 0.0706 | 4.56 | -- | -- | -- | 13.60 | 51.21 | 5.91 | -- | -- | -- |
| LeMaitre Vascular Inc | 240.87m | 53.34m | 1.99bn | 651.00 | 38.47 | 5.25 | 31.30 | 8.27 | 2.28 | 2.28 | 10.35 | 16.71 | 0.494 | 1.03 | 7.45 | 369,993.80 | 10.94 | 9.09 | 11.69 | 9.89 | 70.97 | 66.24 | 22.14 | 16.64 | 11.45 | -- | 0.3077 | 38.38 | 13.63 | 13.40 | 46.28 | 19.68 | 13.11 | 15.91 |
| Alphatec Holdings Inc | 728.02m | -154.96m | 2.00bn | 867.00 | -- | 174.84 | -- | 2.75 | -1.05 | -1.05 | 4.91 | 0.2351 | 0.9497 | 1.28 | 7.90 | 839,700.10 | -20.21 | -27.43 | -26.81 | -34.69 | 69.23 | 66.99 | -21.29 | -39.40 | 1.24 | -1.86 | 0.941 | -- | 26.81 | 40.07 | 13.14 | -- | 48.19 | -- |
| UFP Technologies Inc | 597.95m | 67.12m | 2.03bn | 4.15k | 30.59 | 5.03 | 23.65 | 3.40 | 8.61 | 8.61 | 76.71 | 52.37 | 0.9261 | 4.89 | 6.86 | 144,223.80 | 10.40 | 10.12 | 11.87 | 11.53 | 28.51 | 27.07 | 11.23 | 10.64 | 1.36 | 8.39 | 0.2657 | 0.00 | 26.08 | 20.52 | 31.29 | 24.46 | 10.82 | -- |
| Establishment Labs Holdings Inc | 190.97m | -82.98m | 2.11bn | 1.02k | -- | 129.13 | -- | 11.06 | -2.84 | -2.84 | 6.53 | 0.5632 | 0.6145 | 0.769 | 2.75 | 187,596.30 | -26.70 | -31.53 | -33.25 | -39.32 | 68.74 | 65.46 | -43.45 | -45.09 | 2.10 | -1.72 | 0.9377 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 2.30bn | 699.00 | -- | 8.84 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
| Neogen Corp | 880.32m | -602.74m | 2.34bn | 2.97k | -- | 1.11 | -- | 2.66 | -2.78 | -2.78 | 4.05 | 9.67 | 0.2375 | 2.63 | 5.95 | 296,005.00 | -16.26 | -7.73 | -16.94 | -8.06 | 45.98 | 48.10 | -68.47 | -27.91 | 2.80 | -0.2109 | 0.2737 | -- | -3.20 | 16.43 | -11,491.59 | -- | 34.18 | -- |
| 10X Genomics Inc | 641.81m | -76.32m | 2.42bn | 1.31k | -- | 3.09 | -- | 3.78 | -0.6249 | -0.6249 | 5.19 | 6.20 | 0.6532 | 2.56 | 10.08 | 491,434.90 | -7.77 | -25.61 | -9.00 | -29.19 | 68.90 | 74.03 | -11.89 | -47.52 | 4.06 | -- | 0.00 | -- | -1.28 | 19.96 | 28.41 | -- | -20.72 | -- |
| Haemonetics Corp | 1.32bn | 175.44m | 2.67bn | 3.02k | 15.80 | 2.95 | 9.28 | 2.03 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.45 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| DENTSPLY SIRONA Inc | 3.62bn | -882.00m | 2.74bn | 14.00k | -- | 1.85 | -- | 0.7549 | -4.43 | -4.43 | 18.18 | 7.41 | 0.5903 | 2.72 | 5.47 | 258,857.10 | -14.35 | -4.06 | -18.88 | -4.83 | 51.10 | 53.14 | -24.31 | -8.59 | 0.9865 | 9.68 | 0.6184 | -- | -4.34 | -1.17 | -589.39 | -- | 7.91 | 11.28 |
| Integer Holdings Corp | 1.83bn | 87.20m | 3.05bn | 11.00k | 36.37 | 1.75 | 14.46 | 1.67 | 2.40 | 2.39 | 51.76 | 49.83 | 0.5578 | 5.04 | 4.83 | 166,461.30 | 2.66 | 3.28 | 2.84 | 3.54 | 27.15 | 26.70 | 4.76 | 6.38 | 2.45 | 5.23 | 0.4112 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| LivaNova PLC | 1.35bn | -217.49m | 3.63bn | 2.90k | -- | 3.13 | -- | 2.69 | -4.01 | -4.01 | 24.64 | 21.19 | 0.5311 | 2.58 | 6.60 | 465,159.30 | -8.56 | -4.14 | -11.07 | -5.03 | 68.50 | 67.61 | -16.12 | -9.04 | 1.12 | 10.22 | 0.273 | -- | 8.66 | 2.94 | 260.39 | -- | 10.98 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 5.30m | 11.33% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.37m | 9.33% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2025 | 3.67m | 7.84% |
| AQR Capital Management LLCas of 30 Sep 2025 | 2.13m | 4.55% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.80m | 3.85% |
| River Road Asset Management LLCas of 30 Sep 2025 | 1.65m | 3.54% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.20m | 2.57% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 1.03m | 2.20% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 1.01m | 2.16% |
| Allspring Global Investments LLCas of 31 Dec 2025 | 938.88k | 2.01% |
